Renal Business Today

Robert Chioini

Rockwell's Iron Deficiency Drug Receives Patent

WIXOM, Mich.—The U.S. Patent and Trademark Office has issued a patent to Rockwell Medical for its propriety GMP (good manufacturing process) formulation for its iron drug Soluble Ferric Pyrophosphate (SFP). ...More
October 26, 2010
Posted in News, Business, Government & Regulation
Rockwell Names New VP of Investor Relations

WIXOM, Mich.—Rockwell Medical announced Oct. 5 that it has appointed Carl Belczynski, PhD, as Vice President of Investor Relations. ...More
October 5, 2010
Posted in News, Business
Rockwell, FDA Complete Phase II Meeting for Iron Drug

WIXOM, Mich.—Rockwell Medical said July 8 that it has successfully completed an “End of Phase II” meeting with the U.S. Food and Drug Administration (FDA) regarding its iron-replacement therapy for dialysis patients. ...More
July 8, 2010
Posted in News, Clinical & Pharma, Government & Regulation
Rockwell Appoints Strobos to Scientific Advisory Board

Rockwell Medical Technologies has appointed Jur Strobos, MD, to its scientific advisory board. ...More
October 7, 2009
Posted in News, Business, Clinical & Pharma
Rockwell Looking to Start New Iron Age

Iron management in dialysis patients today is largely done intravenously; however, in the next few years Wixom, Mich.-based Rockwell Medical Technologies hopes to have a new dialysate-delivered iron drug on the market that could improve iron care, as well as save money. ...More
June 5, 2009
Posted in Articles, Business, Clinical & Pharma
Rockwell Completes Patient Enrollment for Phase 2b Study

WIXOM, Mich.—Rockwell Medical Technologies, Inc., a manufacturer and developer of concentrates and specialty pharmaceuticals for dialysis patients, reported that patient enrollment has been completed for its ongoing Phase 2b dose-ranging study for its iron deficiency anemia ...More
April 30, 2009
Posted in News, Business, Clinical & Pharma, Practice Management
Rockwell Medical Updates DSMB Interim Results

WIXOM, Mich.—Rockwell Medical Technologies, Inc., a manufacturer and developer of concentrates and specialty pharmaceuticals for dialysis patients, reported the independent Data Safety Monitoring Board (DSMB) providing oversight for the ongoing SFP Phase 2b dose-range study ...More
April 16, 2009
Posted in News, Business, Clinical & Pharma

featured links

HOT TOPICS

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Robert Chioini

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail